These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 13766296)

  • 1. The leishmanin test and immunity in kala azar.
    MANSON-BAHR PE
    East Afr Med J; 1961 Apr; 38():165-7. PubMed ID: 13766296
    [No Abstract]   [Full Text] [Related]  

  • 2. Leishmanin test in Indian kala-azar.
    Neogy AB; Nandy A; Dastidar BG; Chowdhury AB
    Trans R Soc Trop Med Hyg; 1986; 80(3):454-5. PubMed ID: 3798542
    [No Abstract]   [Full Text] [Related]  

  • 3. Leishmanin test in post-kala-azar dermal leishmaniasis.
    Neogy AB; Nandy A; Chowdhury AB
    Trans R Soc Trop Med Hyg; 1990; 84(1):58. PubMed ID: 2345927
    [No Abstract]   [Full Text] [Related]  

  • 4. Impaired cell-mediated immunity in patients with kala-azar.
    Hepner Levy L; Mendes E
    Allergol Immunopathol (Madr); 1981; 9(2):109-12. PubMed ID: 7293874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmanin test survey in an endemic village of Indian kala-azar near Calcutta.
    Nandy A; Neogy AB; Chowdhury AB
    Ann Trop Med Parasitol; 1987 Dec; 81(6):693-9. PubMed ID: 3503646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of leishmanin skin test antigen sensitivity and potency in a longitudinal study of visceral leishmaniasis in Bangladesh.
    Bern C; Amann J; Haque R; Chowdhury R; Ali M; Kurkjian KM; Vaz L; Wagatsuma Y; Breiman RF; Secor WE; Maguire JH
    Am J Trop Med Hyg; 2006 Oct; 75(4):744-8. PubMed ID: 17038705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of an improved method for the recombinant k 39 enzyme-linked immunosorbent assay to detect visceral leishmaniasis disease and infection in Bangladesh.
    Kurkjian KM; Vaz LE; Haque R; Cetre-Sossah C; Akhter S; Roy S; Steurer F; Amann J; Ali M; Chowdhury R; Wagatsuma Y; Williamson J; Crawford S; Breiman RF; Maguire JH; Bern C; Secor WE
    Clin Diagn Lab Immunol; 2005 Dec; 12(12):1410-5. PubMed ID: 16339064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post kala azar dermal leishmaniasis in Sudan.
    Kordofani YM; Nour YT; El-Hassan AM; Shalayel MH
    East Mediterr Health J; 2001 Nov; 7(6):1061-4. PubMed ID: 15332749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India.
    Mathur P; Samantaray J; Chauhan NK
    Indian J Med Res; 2005 Dec; 122(6):485-90. PubMed ID: 16517998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunity in kala-azar.
    MANSON-BAHR PE
    Trans R Soc Trop Med Hyg; 1961 Nov; 55():550-5. PubMed ID: 14469435
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the immunology and serology of leishmaniasis. IX. Serological investigation of the parasites of Indian kala-azar and Indian post-kala-azar dermal leishmaniasis.
    Bray RS; Ashford RW; Mukherjee AM; Sen Gupta PC
    Trans R Soc Trop Med Hyg; 1973; 67(1):125-9. PubMed ID: 4777392
    [No Abstract]   [Full Text] [Related]  

  • 12. Noninvasive management of Indian visceral leishmaniasis: clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit.
    Sundar S; Sahu M; Mehta H; Gupta A; Kohli U; Rai M; Berman JD; Murray HW
    Clin Infect Dis; 2002 Sep; 35(5):581-6. PubMed ID: 12173133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiology of visceral leishmaniasis and asymptomatic leishmanial infection in a highly endemic Bangladeshi village.
    Bern C; Haque R; Chowdhury R; Ali M; Kurkjian KM; Vaz L; Amann J; Wahed MA; Wagatsuma Y; Breiman RF; Williamson J; Secor WE; Maguire JH
    Am J Trop Med Hyg; 2007 May; 76(5):909-14. PubMed ID: 17488915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of new antigens in visceral leishmaniasis by expression cloning and immunoblotting with sera of kala-azar patients from Bihar, India.
    Theinert SM; Basu R; Forgber M; Roy S; Sundar S; Walden P
    Infect Immun; 2005 Oct; 73(10):7018-21. PubMed ID: 16177384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sensitive ELISA for detection of circulating antigens in kala azar patients.
    Sinha R; Arora SK; Sehgal S
    Indian J Med Res; 1988 Aug; 88():138-40. PubMed ID: 3198171
    [No Abstract]   [Full Text] [Related]  

  • 16. Kala-azar infected serum circulating antigens and their characteristics detected by monoclonal antibody.
    Hu XS; Liu Q; Lin FQ; Yi TL; Wang YJ; Qin Z; Luo P; Wang L
    Chin Med J (Engl); 1988 Jan; 101(1):1-6. PubMed ID: 3142725
    [No Abstract]   [Full Text] [Related]  

  • 17. Challenges in the diagnosis of post kala-azar dermal leishmaniasis.
    Salotra P; Singh R
    Indian J Med Res; 2006 Mar; 123(3):295-310. PubMed ID: 16778312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunology of post-kala-azar dermal leishmaniasis (PKDL).
    Zijlstra EE
    Parasit Vectors; 2016 Aug; 9(1):464. PubMed ID: 27553063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of circulating antigens by McAb-AST for evaluation of the therapeutic effect of kala-azar cases].
    Hu XS; Lin FQ; Liu Q; Wang YJ; Luo P; Qin Z; Bao L; Yuan HS; Lan L
    Hua Xi Yi Ke Da Xue Xue Bao; 1986 Sep; 17(3):161-4. PubMed ID: 3557420
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of amastigote-specific antigens of Leishmania donovani using kala-azar patient sera.
    Gupta N; Goyal N; Bhatia N; Kamboj KK; Rastogi AK
    Indian J Exp Biol; 2001 Jul; 39(7):623-8. PubMed ID: 12019753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.